Outcomes of CD20 Bispecific Antibodies after CD19 CAR T-cell Therapy in mantle cell lymphoma: A Multicenter Analysis from the Collaborative U.S. Bispecific Consortium (CUBIC)Ajay Major, Andrew Jallouk, Shakthi Bhaskar et al.|Transplantation and Cellular Therapy|2026Cited by 0
Outpatient Versus Inpatient Management of Grade 1 Cytokine Release Syndrome in Follicular Lymphoma Patients Receiving Bispecific Antibodies: A Cubic StudyLynnette Henshaw, Jennifer L. Crombie, Sairah Ahmed et al.|Transplantation and Cellular Therapy|2026Cited by 0